Inhalational use of antithrombotics in humans: Review of the literature

Thrombosis Research

Volumn 136, Issue 6, 2015, Pages 1059-1066

  Monagle, K ^a   Ryan, A ^a,c   Hepponstall, M ^a,b   Mertyn, E ^a   Monagle, P ^a,b,c   Ignjatovic, V ^a,b   Newall, F ^a,b,c,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Antithrombotic therapy; Inhaled; Thrombolytic therapy

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ALLERGY; ANTICOAGULANT THERAPY; ARTICLE; ASTHMA; BRONCHITIS; CONTROLLED CLINICAL TRIAL (TOPIC); FIBRINOLYTIC THERAPY; HUMAN; LUNG BURN; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT INDICATION; INHALATIONAL DRUG ADMINISTRATION; VENOUS THROMBOSIS;

ADMINISTRATION, INHALATION; FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; VENOUS THROMBOSIS;

EID: 84949202003     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.10.011     Document Type: Review

References (48)

1. R. Mueller, and S. Scheidt History of drugs for thrombotic disease: discovery, development and directions for the future Circulation 89 1994 432 449
2. C. Crafoord Preliminary report on post-operative treatment with heparin as a preventative of thrombosis Acta Chir. Scand. 79 1937 407 426
3. D. Murray, L. Jaques, T. Perret, and C. Best Heparin and the thrombosis of veins following injury Surgery 2 1937 163 187
4. L. Ng, K. Monagle, P. Monagle, F. Newall, and V. Ignjatovic Topical use of antithrombotics: review of literature Thromb. Res. 135 2015 575 581
5. K.E. Bendstrup, C.B. Chambers, J.I. Jensen, and M.T. Newhouse Lung deposition and clearance of inhaled (99m)Tc-heparin in healthy volunteers Am. J. Respir. Crit. Care Med. 160 1999 1653 1658
6. K.E. Bendstrup, J. Gram, and J.I. Jensen Effect of inhaled heparin on lung function and coagulation in healthy volunteers Eur. Respir. J. 19 2002 606 610
7. J. Harenberg, R. Malsch, M. Angelescu, C. Lange, H.C. Michaelis, H. Wolf, and D.L. Heene Anticoagulant effects and tissue factor pathway inhibitor after intrapulmonary low-molecular-weight heparin Blood Coagul. Fibrinolysis 7 1996 477 483
8. A. Markiewicz, B. Tausz, B. Zahorska-Markiewicz, and J. Nawrot Morning vs evening effects of intrapulmonary administration of heparin in healthy men Int. J. Clin. Pharmacol. Ther. Toxicol. 30 1992 400 404
9. G. Scheuch, P. Brand, T. Meyer, C. Herpich, B. Mullinger, J. Brom, G. Weidinger, M. Kohlhaufl, K. Haussinger, M. Spannagl, W. Schramm, and R. Siekmeier Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects J. Physiol. Pharmacol. 58 Suppl 5 2007 603 614
10. E.L. Kanabrocki, R.B. Sothern, W.F. Bremner, S.A. Gruber, L.E. Scheving, D.L. Bushnell, M. Ryan, M.E. Rubnitz, N. Fabbrini, S. Lampo, and et al. Heparin as a therapy for atherosclerosis: preliminary observations on the intrapulmonary administration of low-dose heparin in the morning versus evening gauged by its effect on blood variables Chronobiol. Int. 8 1991 210 233
11. K. Zawilska, A. Tokarz, A. Misiak, P. Psuja, S. Wislawski, P. Szymczak, J. Meissner, J. Karon, K. Lewandowski, S. Lopaciuk, and et al. Nebulized heparin and anabolic steroid in the prevention of postoperative deep vein thrombosis following elective abdominal surgery Folia Haematol Int Mag Klin Morphol Blutforsch. 117 1990 699 707
12. W. Geerts, D. Bergqvist, G. Pineo, J. Heit, C. Samama, M. Lassen, and C. Colwell Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-based Clinical Practice Guidelines 8th ed 133 2008 6
13. M.H. Desai, R. Mlcak, J. Richardson, R. Nichols, and D.N. Herndon Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/N-acetylcystine [correction of acetylcystine] therapy J. Burn Care Rehabil. 19 1998 210 212
14. B. Dixon, J.D. Santamaria, and D.J. Campbell A phase 1 trial of nebulised heparin in acute lung injury Crit. Care 12 2008 R64
15. J. Holt, J.R. Saffle, S.E. Morris, and A. Cochran Use of inhaled heparin/N-acetylcystine in inhalation injury: does it help? J. Burn Care Res. 29 2008 192 195
16. A.C. Miller, A. Rivero, S. Ziad, D.J. Smith, and E.M. Elamin Influence of nebulized unfractionated heparin and N-acetylcysteine in acute lung injury after smoke inhalation injury J. Burn Care Res. 30 2009 249 256
17. A. Chopra, B. Burkey, and S. Calaman A case report of clinically significant coagulopathy associated with aerosolized heparin and acetylcystein therapy for inhalation injury Burns 37 2011 e73 e75
18. L. Yip, Y. Lim, and H. Chan Safety and potential anticoagulant effects of nebulised heparin in burns patients with inhalational injury at Singapore General Hospital Burns Centre Burns 37 2011 1154 1160
19. P. Monagle, C. Barnes, V. Ignjatovic, J. Furmedge, F. Newall, A. Chan, L. DeRosa, S. Hamilton, P. Ragg, S. Robinson, A. Auldist, C. Crock, and S. Rowlands Developmental haemostasis: impact for clinical haemostasis laboratories Thromb. Haemost. 95 2006 362 372
20. K. Bendstrup, and J. Jensen Inhaled heparin is effective in exacerbations of asthma Respir. Med. 94 2000 174 175
21. J. Garrigo, I. Danta, and T. Ahmed Time course of the protective effect of inhaled heparin on exercise-induced asthma Am. J. Respir. Crit. Care Med. 153 1996 1702 1707
22. T. Ahmed, J. Garrigo, and I. Danta Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin The New England Journal of Medicine. 329 1993 90 95
23. T. Ahmed, B. Gonzalez, and I. Danta Prevention of exercise-induced bronchoconstriction by inhaled low molecular weight heparin Am. J. Respir. Crit. Care Med. 160 1999 576 581
24. A. Kalpaklioglu, Y. Demirel, S. Saryal, and Z. Misirligil Effect of pretreatment with heparin on pulmonary and cutaneous response J. Asthma 34 1997 337 343
25. B. Ceyhan, and T. Celikel Effect of inhaled heparin on methacholine-induced bronchial hyperreactivity Chest 107 1995 1009 1012
26. I. Pavord, T. Mudassar, J. Bennett, P. Wilding, and A. Knox The effect of inhaled heparin on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma Eur. Respir. J. 9 1996 217 219
27. B. Ceyhan, and T. Celikel Effect of inhaled heparin on adenosine-induced bronchial hyperreactivity Int. J. Clin. Pharmacol. Ther. 35 1997 208 213
28. B. Ceyhan, and T. Celikel Effect of inhaled low molecular weight heparin on methacholine-induced bronchoconstriction Int. J. Clin. Pharmacol. Ther. 38 2000 446 451
29. R. Polosa, S. Magri, C. Vancheri, F. Armato, G. Santonocito, A. Mistretta, and N. Crimi Time course of changes in adenosine 5'-monophosphate airway responsiveness with inhaled heparin in allergic patients J. Allergy Clin. Immunol. 99 1997
30. B. Tutluoglu, N. Gurbuz, S. Abanozlu, R. Ibis, and A. Kanik Effects of heparin on hypertonic potassium chloride-induced bronchoconstriction The Annals of Pharmacotherapy. 35 2001 1161 1165
31. Z. Diament, M. Timmers, H. van der Veen, C. Page, F. van der Meer, and P. Sterk Effects of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma Am. J. Respir. Crit. Care Med. 153 1996 1790 1795
32. 4 Allergy Asthma Proc. 24 2003 59 65
33. C. Tranfa, A. Vatrella, R. Parrella, G. Pelaia, F. Bariffi, and S. Marsico Effect of inhaled heparin on water-induced bronchoconstriction in allergic asthmatics Eur. J. Clin. Pharmacol. 57 2001 5 9
34. J.M. Costello, D. Steinhorn, S. McColley, M.E. Gerber, and S.P. Kumar Treatment of plastic bronchitis in a Fontan patient with tissue plasminogen activator: a case report and review of the literature Pediatrics 109 2002 e67
35. T.B. Do, J.M. Chu, F. Berdjis, and N.G. Anas Fontan patient with plastic bronchitis treated successfully using aerosolized tissue plasminogen activator: a case report and review of the literature Pediatr. Cardiol. 30 2009 352 355
36. M.K. Wakeham, A.H. Van Bergen, L.E. Torero, and J. Akhter Long-term treatment of plastic bronchitis with aerosolized tissue plasminogen activator in a Fontan patient Pediatr. Crit. Care Med. 6 2005 76 78
37. H.J. Zaccagni, L. Kirchner, J. Brownlee, and K. Bloom A case of plastic bronchitis presenting 9 years after Fontan Pediatr. Cardiol. 29 2008 157 159
38. G. Grutter, D. DiCarlo, F. Gandolfo, R. Adorisio, S. Alfieri, G. Michielon, A. Carotti, and G. Pongiglione Plastic bronchitis after extracardiac Fontan operation Ann. Thorac. Surg. 94 2012 860 864
39. N.N. Lubcke, V.M. Nussbaum, and M. Schroth Use of aerosolized tissue plasminogen activator in the treatment of plastic bronchitis Ann. Pharmacother. 47 2013 e13 e17
40. M.W. Quasney, K. Orman, J. Thompson, J.C. Ring, M. Salim, R.A. Schoumacher, D. Watson, W. Novick, S.R. Deitcher, and R. Joyner Plastic bronchitis occurring late after the Fontan procedure: treatment with aerosolized urokinase Crit. Care Med. 28 2000 2107 2111
41. J. Weiler, S. Quinn, G. Woodworth, D. Brown, T. Layton, and K. Maves Does heparin prophylaxis prevent exacerbations of hereditary angioedema? J. Allergy Clin. Immunol. 109 2002 995 1000
42. D. Serisier, J. Shute, P. Hockey, B. Higgins, J. Conway, and M. Carroll Inhaled heparin in cystic fibrosis Eur Respir. J. 27 2006 354 358
43. V. Efimov, M. Fyodorova, and V. Petrukhin Administration of heparin inhalations for correction of blood antithrombin activity in pregnant women with IDDM Int. J. Gynecol. Obstet. 48 1995 219 220
44. P. Hedenius, and O. Wilander The influence of intravenous injections of heparin in man on the time of coagulation Acta Med. Scand. 88 1936 443 449
45. D. Garcia, T. Baglin, J. Weitz, and M. Meyer Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines Chest 141 2012 e24S e43S
46. A. Holbrook, S. Schulman, D. Witt, P. Vandvik, J. Fish, M. Kovacs, P. Svensson, D. Veenstra, M.A. Crowther, and G. Guyatt Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines Chest 141 2012 e152S e184S
47. C. Kearon, E. Akl, A. Comerota, P. Prandoni, H. Bounameaux, S. Goldhaber, M. Nelson, P. Wells, M. Gould, F. Dentali, M.A. Crowther, and S. Kahn Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines Chest 141 2012 e419S e494S
48. S. Idell Coagulation, fibrinolysis, and fibrin deposition in acute lung injury Crit. Care Med. 31 2003 S213 S220